{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1636, 
        1650
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1808, 
        1831
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3906, 
        3914
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1558, 
        1585
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        530, 
        559
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1846, 
        1881
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1463, 
        1489
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1601, 
        1609
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1626, 
        1635
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1530, 
        1534
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1541, 
        1544
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1551, 
        1555
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1547, 
        1549
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1598, 
        1600
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1765, 
        1767
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 1^9999^MOH|PIMS|CCO|20160506115818|38CE6ED8ACDB4C887D219DFDD297C66675DE5485|ORU^R01|Q1910406211T3586193530|P|2.5|\nPID|1||WH999999^^^^CMR^HOSPITAL 1&9999&MOH~WH999999^^^^MRN^HOSPITAL 1&9999&MOH~9999999999&KP&ON^^^^JHN||XXXXXXXX^XXXXXXXXXX||99999999|M|||99 XXXXXXX XX.^^XXXXXXXXX^XXX^X9X9X9^999||||||||||||||||Unknown|||N|\nOBR|1||WS-16-0002972|11529-5^Surgical Pathology Study Report^LN^P^Pathology^L|||20160504|||80585^XXXXX^XXXX^XXXXXXXX X.||||||||||N||20160506|||F|||||||99999^XXXXXXX^XXXXX|\n\n\n\n\n\n\n\nPath report.gross description\n\n\nA: Labelled A Rt base - The specimen consists of 3 cores of pale tan tissue, the largest measuring 2.0 cm. All tissue submitted one cassette. \n\nB: Labelled B Rt mid - The specimen consists of 3 cores of pale tan tissue, the largest measuring 1.5 cm. All tissue submitted one cassette. \n\nC: Labelled C Rt apex - The specimen consists of 3 cores of pale tan tissue, the largest measuring 2.1 cm. All tissue submitted one cassette. \n\nD: Labelled D Lt base - The specimen consists of 3 cores of pale tan tissue, the largest measuring 1.6 cm. All tissue submitted one cassette. \n\nE: Labelled E Lt mid - The specimen consists of 2 cores and 1 fragment of pale tan tissue, the largest measuring 1.3 cm. All tissue submitted one cassette. \n\nF: Labelled F Lt apex - The specimen consists of 2 cores of pale tan tissue, the largest measuring 2.2 cm. All tissue submitted one cassette.  MA/sj 2016/05/05 10:31\n\n\nPath report.site of origin\n\n\nA Rt. Base\nB Rt. Mid\nC Rt. Apex\nD Lt. Base\nE Lt. Mid\nF Lt. Apex\n\n\nPath report.final diagnosis\n\n\nA through F. Prostate; core biopsies: prostatic adenocarcinoma (see synoptic report for details).\n\nSecondary review on 1 slide of each of parts A through F was performed by Dr. D.F. Liu who concurs with the diagnosis.\n\n\nPath report.relevant Hx\n\n\nPSA = 276\n\n\nPath report.microscopic observation\n\n\nA : Prostate biopsy, right base PZ:  \n   positive for prostatic adenocarcinoma \n      Gleason Score: 9 / 10 \n      number of cores involved / number of cores submitted: 3/3 \n      percent of tissue involved in this specimen: 90%; 41 mm \n \nB : Prostate biopsy, right mid PZ:  \n   positive for prostatic adenocarcinoma \n      Gleason Score: 9 / 10 \n      number of cores involved / number of cores submitted: 3/3 \n      percent of tissue involved in this specimen: 75%; 26 mm \n \nC : Prostate biopsy, right apex PZ:  \n   positive for prostatic adenocarcinoma \n      Gleason Score: 9 / 10 \n      number of cores involved / number of cores submitted: 3/3 \n      percent of tissue involved in this specimen: 85%; 37 mm \n \nD : Prostate biopsy, left base PZ:  \n   positive for prostatic adenocarcinoma \n      Gleason Score: 9 / 10 \n      number of cores involved / number of cores submitted: 2/2 \n      percent of tissue involved in this specimen: 48%; 14 mm \n \nE : Prostate biopsy, left mid PZ:  \n   positive for prostatic adenocarcinoma \n      Gleason Score: 9 / 10 \n      number of cores involved / number of cores submitted: 2/2 \n      percent of tissue involved in this specimen: 74%; 20 mm \n \nF : Prostate biopsy, left apex PZ:  \n   positive for prostatic adenocarcinoma \n      Gleason Score: 9 / 10 \n      number of cores involved / number of cores submitted: 2/2 \n      percent of tissue involved in this specimen: 38%; 12 mm \n \n------------------------- \nCASE SUMMARY \n------------------------- \nPositive for prostatic adenocarcinoma \n \nOverall Gleason score: 5+4=9 /10 \nPercentage of Gleason patterns 4 and/or 5: 95% \nEstimated percentage of adenocarcinoma in all specimens: 68% \nNumber of positive specimens / total number of specimens submitted: 6/6 \nPerineural invasion: absent \nInvasion of periprostatic adipose tissue: absent \nAtypical small acinar proliferation (ASAP): absent \nHigh grade prostatic intraepithelial neoplasia (HGPIN): absent \nAcute inflammation: absent \nSignificant chronic inflammation: absent \n \nComment: Immunohistochemistry on part A shows nonreactivity for chromogranin and very focal reactivity for synaptophysin.\n\n\n"
}